Despite active caspase-1 upregulation (Figure 5A,B), there were no significant differences in IL-1β secretion in response to Tim-3 or Gal-9 knockdown in any of the glioma cell lines (Supplementary Figure S11A,B). The gene discussed is CASP1; the disease is central nervous system cancer.